Literature DB >> 27160223

Tau PET and tauopathies.

Karl Herholz1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27160223     DOI: 10.1007/s00259-016-3406-5

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN: 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  11 in total

1.  Regional profiles of the candidate tau PET ligand 18F-AV-1451 recapitulate key features of Braak histopathological stages.

Authors:  Adam J Schwarz; Peng Yu; Bradley B Miller; Sergey Shcherbinin; James Dickson; Michael Navitsky; Abhinay D Joshi; Michael D Devous; Mark S Mintun
Journal:  Brain       Date:  2016-03-02       Impact factor: 13.501

Review 2.  Tau imaging in the study of ageing, Alzheimer's disease, and other neurodegenerative conditions.

Authors:  Victor L Villemagne; Nobuyuki Okamura
Journal:  Curr Opin Neurobiol       Date:  2015-09-20       Impact factor: 6.627

3.  Evaluation of a calibrated (18)F-FDG PET score as a biomarker for progression in Alzheimer disease and mild cognitive impairment.

Authors:  Karl Herholz; Sarah Westwood; Cathleen Haense; Graham Dunn
Journal:  J Nucl Med       Date:  2011-07-15       Impact factor: 10.057

4.  Performance characteristics of amyloid PET with florbetapir F 18 in patients with alzheimer's disease and cognitively normal subjects.

Authors:  Abhinay D Joshi; Michael J Pontecorvo; Chrisopher M Clark; Alan P Carpenter; Danna L Jennings; Carl H Sadowsky; Lee P Adler; Karel D Kovnat; John P Seibyl; Anupa Arora; Krishnendu Saha; Jason D Burns; Mark J Lowrey; Mark A Mintun; Daniel M Skovronsky
Journal:  J Nucl Med       Date:  2012-02-13       Impact factor: 10.057

Review 5.  Tau imaging: early progress and future directions.

Authors:  Victor L Villemagne; Michelle T Fodero-Tavoletti; Colin L Masters; Christopher C Rowe
Journal:  Lancet Neurol       Date:  2015-01       Impact factor: 44.182

6.  PET Imaging of Tau Deposition in the Aging Human Brain.

Authors:  Michael Schöll; Samuel N Lockhart; Daniel R Schonhaut; James P O'Neil; Mustafa Janabi; Rik Ossenkoppele; Suzanne L Baker; Jacob W Vogel; Jamie Faria; Henry D Schwimmer; Gil D Rabinovici; William J Jagust
Journal:  Neuron       Date:  2016-03-02       Impact factor: 17.173

7.  18F-THK5351: A Novel PET Radiotracer for Imaging Neurofibrillary Pathology in Alzheimer Disease.

Authors:  Ryuichi Harada; Nobuyuki Okamura; Shozo Furumoto; Katsutoshi Furukawa; Aiko Ishiki; Naoki Tomita; Tetsuro Tago; Kotaro Hiraoka; Shoichi Watanuki; Miho Shidahara; Masayasu Miyake; Yoichi Ishikawa; Rin Matsuda; Akie Inami; Takeo Yoshikawa; Yoshihito Funaki; Ren Iwata; Manabu Tashiro; Kazuhiko Yanai; Hiroyuki Arai; Yukitsuka Kudo
Journal:  J Nucl Med       Date:  2015-11-05       Impact factor: 10.057

8.  CSF phosporylated TAU protein levels correlate with cerebral glucose metabolism assessed with PET in Alzheimer's disease.

Authors:  R Ceravolo; D Borghetti; L Kiferle; G Tognoni; A Giorgetti; D Neglia; N Sassi; D Frosini; C Rossi; L Petrozzi; G Siciliano; L Murri
Journal:  Brain Res Bull       Date:  2008-02-11       Impact factor: 4.077

Review 9.  Identifying and validating biomarkers for Alzheimer's disease.

Authors:  Christian Humpel
Journal:  Trends Biotechnol       Date:  2010-10-23       Impact factor: 19.536

Review 10.  Tau imaging in neurodegenerative diseases.

Authors:  M Dani; D J Brooks; P Edison
Journal:  Eur J Nucl Med Mol Imaging       Date:  2015-11-16       Impact factor: 9.236

View more
  1 in total

1.  [18F]-THK5351 PET Correlates with Topology and Symptom Severity in Progressive Supranuclear Palsy.

Authors:  Matthias Brendel; Sonja Schönecker; Günter Höglinger; Simon Lindner; Joachim Havla; Janusch Blautzik; Julia Sauerbeck; Guido Rohrer; Christian Zach; Franziska Vettermann; Anthony E Lang; Lawrence Golbe; Georg Nübling; Peter Bartenstein; Katsutoshi Furukawa; Aiko Ishiki; Kai Bötzel; Adrian Danek; Nobuyuki Okamura; Johannes Levin; Axel Rominger
Journal:  Front Aging Neurosci       Date:  2018-01-17       Impact factor: 5.750

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.